Back to search

Article

Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres

2024-05-28

Abstract excerpt

<title>Abstract</title><p>Breast cancer remains a significant global health challenge. In Australia, the adoption of publicly-funded multigene panel testing for eligible cancer patients has increased accessibility to personalised care, yet has also highlighted the increasing prevalence of variants of uncertain significance (VUS), complicating clinical decision-making. This project aimed to explore the spectrum and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f32ed4ed-9d3d-5cda-a056-f75addad347c
DOI
10.21203/rs.3.rs-4352556/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centresDOI 10.21203/rs.3.rs-4352556/v1
Unrecognised actionability for breast cancer risk variants identified in a national-level review of Australian familial cancer centres.Semantic proximity
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.Semantic proximity
Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.Semantic proximity
From Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceSemantic proximity
Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.Semantic proximity
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert PanelSemantic proximity
BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.Semantic proximity
Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.Semantic proximity
Half of germline pathogenic and likely pathogenic variants found on panel tests do not fulfil NHS testing criteria.Semantic proximity
Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesSemantic proximity
Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.Semantic proximity
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification.Semantic proximity
Select a neighboring publication to make it the new centre.